Results 101 to 110 of about 2,327,467 (213)

Urbanicity and Lifestyle Risk Factors for Cardiometabolic Diseases in Rural Uganda: A Cross-Sectional Study

, 2014
Urbanicity and Lifestyle Risk Factors for Cardiometabolic Diseases in Rural Uganda: A Cross-Sectional ...
J Seeley (13699720), G Ssenyomo (13699711), A Kamali (13511632), J Riha (13699705), EH Young (14466816), Steven Allender (13057743), G Asiki (10672488), MS Sandhu (7672526), A Karabarinde (13699708)   +8 more
core  

Walking the VLDL tightrope in cardiometabolic diseases

Trends in Endocrinology & Metabolism
Very-low-density lipoprotein (VLDL), a triglyceride-rich lipoprotein secreted by hepatocytes, is pivotal for supplying peripheral tissues with fatty acids for energy production. As if walking on a tightrope, perturbations in the balance of VLDL metabolism contribute to cardiometabolic dysfunction, promoting pathologies such as cardiovascular disease ...
Mindy Kim, Ze Zheng
openaire   +3 more sources

Exploring neutrophils as therapeutic targets in cardiometabolic diseases

Current therapies for diabetes and atherosclerotic cardiovascular diseases (ACVDs) mainly target metabolic risk factors, but often fall short in addressing systemic inflammation, a key driver of disease onset and progression.
Albiero M., Baragetti A., Baragetti, Andrea, Albiero, Mattia   +3 more
core   +2 more sources

The association between sleep disorders and the risk of atherosclerotic cardiovascular disease: regression analysis and neural network prediction based on NHANES data

Journal of Cardiothoracic Surgery
Background Sleep quality and duration play a critical role in cardiovascular health. In recent years, sleep disorders have been identified as potential risk factors for atherosclerotic cardiovascular disease (ASCVD).
Ling-bing Meng, Kongyong Cui, Yanjun Song, Bowen Li, Yongbao Zhang, Kefei Dou   +5 more
doaj   +1 more source

Target acquired: Selective autophagy in cardiometabolic disease

, 2017
Boosting the autophagic degradation of dysfunctional organelles could be used to treat various cardiometabolic diseases.
Babak Razani, Ismail Sergin, Xiangyu Zhang, Trent D. Evans   +3 more
core   +1 more source

Pulse pressure associates with severity and worse outcomes in patients with stable coronary artery disease

npj Cardiovascular Health
The association of pulse pressure (PP) with the severity and cardiovascular (CV) outcomes in stable coronary artery disease populations with normal ejection fraction are sparse.
Yan Zhang, Sha Li, Hui-Wen Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Rui-Xia Xu, Jie Qian, Ke-Fei Dou, Jian-Jun Li   +9 more
doaj   +1 more source

Environmental Risk Conditions and Pathways to Cardiometabolic Diseases in Indigenous Populations

, 2011
This review examines environments in relation to cardiometabolic diseases in Indigenous populations in developed countries. Environmental factors are framed in terms of context (features of places) and composition (features of populations).
Ivana Stankov, Mark Daniel, Stankov, Ivana, Brown, A., Lekkas, P., Stankov, I., CARGO, Margaret, Daniel, M., Cargo, M.D., DANIEL, Mark, Alex Brown, Margaret Cargo, Brown, Alex, Lekakas, Peter, Peter Lekkas   +14 more
core   +1 more source

Bacteriophages, gut bacteria, and microbial pathways interplay in cardiometabolic health [PDF]

Cardiometabolic diseases are leading causes of mortality in Western countries. Well-established risk factors include host genetics, lifestyle, diet, and the gut microbiome.
Daniel Kirk, Costeira, Ricardo, Valdes, Ana M, Ana M. Valdes, Visconti, Alessia, Mohammadali Khan Mirzaei, Menni, Cristina, Cristina Menni, Alessia Visconti, Deng, Li, Ricardo Costeira, Li Deng, Khan Mirzaei, Mohammadali, Kirk, Daniel, Valdes, Ana M.   +14 more
core   +1 more source

Extensive molecular profiling of systemic metabolism to understand and prevent cardiometabolic diseases

Cardiometabolic diseases –coronary heart disease, stroke and diabetes– are the leading cause of death and disability in Australia. I am tackling these diseases by novel technologies in large-scale epidemiology to identify new biomarkers and obtain ...

core  

The cholesterol, high-density lipoprotein, and glucose (CHG) index as a novel metabolic marker for predicting adverse outcomes in myocardial infarction survivors: insights from two large prospective cohorts

Cardiovascular Diabetology
Background Post-myocardial infarction (MI) patients remain at high risk of mortality and recurrent cardiovascular events. Metabolic disorders in patients after MI are closely related to high residual cardiovascular risk.
Yanjun Song, Xinyue Chen, Zhen’ge Chang, Xiaohui Bian, Jining He, Bowen Li, Zhihao Zheng, Chunyue Wang, Zhangyu Lin, Chen Zhu, Rui Fu, Kefei Dou   +11 more
doaj   +1 more source